Portes Ana Beatriz, Panzenhagen Pedro, Pereira Dos Santos Anamaria Mota, Junior Carlos Adam Conte
Center for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro 21941-598, Brazil.
Laboratory of Advanced Analysis in Biochemistry and Molecular Biology (LAABBM), Department of Biochemistry, Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro 21941-909, Brazil.
Antibiotics (Basel). 2023 Mar 9;12(3):548. doi: 10.3390/antibiotics12030548.
In recent years, has become increasingly resistant to antibiotics, especially those first-choice drugs used to treat campylobacteriosis. Studies in South America have reported cases of antibiotic-resistant in several countries, mainly in Brazil. To understand the current frequency of antibiotic-resistant in humans, farm animals, and food of animal origin in South America, we systematically searched for different studies that have reported resistance. The most commonly reported species were and . Resistance to ciprofloxacin was found to be ubiquitous in the isolates. Nalidixic acid and tetracycline showed a significantly expressed resistance. Erythromycin, the antibiotic of first choice for the treatment of campylobacteriosis, showed a low rate of resistance in isolates but was detected in almost all countries. The main sources of antibiotic-resistant isolates were food of animal origin and farm animals. The results demonstrate that resistant isolates are disseminated from multiple sources linked to animal production in South America. The level of resistance that was identified may compromise the treatment of campylobacteriosis in human and animal populations. In this way, we are here showing all South American communities the need for the constant surveillance of resistance and the need for the strategic use of antibiotics in animal production. These actions are likely to decrease future difficulties in the treatment of human campylobacteriosis.
近年来,[具体细菌名称未给出]对抗生素的耐药性越来越强,尤其是那些用于治疗弯曲菌病的一线药物。南美洲的研究报告了几个国家出现抗生素耐药性[具体细菌名称未给出]的病例,主要在巴西。为了解南美洲人类、农场动物和动物源性食品中抗生素耐药性[具体细菌名称未给出]的当前频率,我们系统地搜索了报告[具体细菌名称未给出]耐药性的不同研究。最常报告的物种是[具体物种名称未给出]和[具体物种名称未给出]。发现环丙沙星耐药性在分离株中普遍存在。萘啶酸和四环素显示出显著的耐药性。红霉素是治疗弯曲菌病的首选抗生素,在分离株中的耐药率较低,但在几乎所有国家都有检测到。抗生素耐药性[具体细菌名称未给出]分离株的主要来源是动物源性食品和农场动物。结果表明,耐药性[具体细菌名称未给出]分离株是从南美洲与动物生产相关的多个来源传播的。所确定的耐药水平可能会影响人类和动物群体中弯曲菌病的治疗。通过这种方式,我们在此向所有南美洲社区表明,需要持续监测[具体细菌名称未给出]的耐药性以及在动物生产中战略性使用抗生素的必要性。这些行动可能会减少未来人类弯曲菌病治疗中的困难。